AU4668797A - Replication-defective adenoviruses for cancer immunotherapy - Google Patents

Replication-defective adenoviruses for cancer immunotherapy

Info

Publication number
AU4668797A
AU4668797A AU46687/97A AU4668797A AU4668797A AU 4668797 A AU4668797 A AU 4668797A AU 46687/97 A AU46687/97 A AU 46687/97A AU 4668797 A AU4668797 A AU 4668797A AU 4668797 A AU4668797 A AU 4668797A
Authority
AU
Australia
Prior art keywords
replication
cancer immunotherapy
defective adenoviruses
adenoviruses
defective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46687/97A
Inventor
Jean-Charles Cerrottini
C. Victor Jongeneel
Darryl S. Reed
Donata Rimoldi
Pedro Romero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Original Assignee
Ludwig Institute for Cancer Research Ltd
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research Ltd
Publication of AU4668797A publication Critical patent/AU4668797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU46687/97A 1996-10-07 1997-10-06 Replication-defective adenoviruses for cancer immunotherapy Abandoned AU4668797A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2789196P 1996-10-07 1996-10-07
US60027891 1996-10-07
PCT/US1997/017948 WO1998015638A2 (en) 1996-10-07 1997-10-06 Replication-defective adenoviruses for cancer immunotherapy

Publications (1)

Publication Number Publication Date
AU4668797A true AU4668797A (en) 1998-05-05

Family

ID=21840363

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46687/97A Abandoned AU4668797A (en) 1996-10-07 1997-10-06 Replication-defective adenoviruses for cancer immunotherapy

Country Status (3)

Country Link
AU (1) AU4668797A (en)
WO (1) WO1998015638A2 (en)
ZA (1) ZA978959B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001016320A1 (en) * 1999-08-30 2001-03-08 Ludwig Institute For Cancer Research Isolated nona and decapeptides which bind to hla molecules, and the use thereof
US6756044B1 (en) 2000-02-09 2004-06-29 Genvec, Inc. Antigenic complexes and methods
EP2412792A1 (en) 2010-07-29 2012-02-01 The Procter & Gamble Company Liquid detergent composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08506015A (en) * 1993-01-22 1996-07-02 ラドウィック インスティテュート フォア キャンサー リサーチ Method for identifying and treating individuals with cancer cells expressing HLA-C-clone 10 / MAGE-1
US5543328A (en) * 1993-08-13 1996-08-06 Genetic Therapy, Inc. Adenoviruses having modified fiber proteins
US6100242A (en) * 1995-02-28 2000-08-08 The Regents Of The University Of California Gene therapies for enhancing cardiac function
FR2746110B1 (en) * 1996-03-14 1998-04-17 METHOD OF TREATING GENE THERAPY OF HUMAN TUMORS AND CORRESPONDING RECOMBINANT VIRUSES

Also Published As

Publication number Publication date
WO1998015638A3 (en) 1998-07-02
WO1998015638A2 (en) 1998-04-16
ZA978959B (en) 1998-06-23

Similar Documents

Publication Publication Date Title
IL130899A0 (en) Adenoviruses having altered hexon proteins
AU3968397A (en) Secure boot
AU4230896A (en) Cancer inhibitory peptides
AU7249596A (en) Self-tightening shoe
AU5703398A (en) Novel compounds
AU2033797A (en) Promoter
AU5372598A (en) Tfpx synthesis
AU1614297A (en) Protective means
AU4747997A (en) Interstitial sector system
AU3758097A (en) Winch
AU5423298A (en) Novel compounds
AU4668797A (en) Replication-defective adenoviruses for cancer immunotherapy
AU2142597A (en) Binding for snowboards
AU3902397A (en) Magnetron
AU1581397A (en) Novel tumor suppressor gene, dpc4
AU1112997A (en) Centrifugal grinder
AU3711697A (en) Novel compounds
AU3757997A (en) Winch
AU2687597A (en) Grinder
AU4359297A (en) Winch
AU3036197A (en) Adenovirus vectors for gene therapy
AU1041597A (en) Remedy for tragomaschalia containing adrenocorticosteriodal preparation
AU4483597A (en) Novel tumor proteins
AU4874097A (en) Metallacarboranes
AU4502797A (en) Immunological therapy for cancer